Therefore, RARβ could act as tumor suppressor even in the absence of ATRA, and RARβ loss expression gives AP-1 over-expression, which could abrogate the growth-inhibitory effects of ATRA through RARα and RARγ, resulting in retinoid resistance [222]. Here, RARA is linked to neoplasm.